Annexin A2

Its molecular regulation and cellular expression in cancer development

Chi Yun Wang, Chiou Feng Lin

Research output: Contribution to journalArticle

60 Citations (Scopus)

Abstract

Annexin A2 (ANXA2) orchestrates multiple biologic processes and clinical associations, especially in cancer progression. The structure of ANXA2 affects its cellular localization and function. However, posttranslational modification and protease-mediated N-terminal cleavage also play critical roles in regulating ANXA2. ANXA2 expression levels vary among different types of cancers. With some cancers, ANXA2 can be used for the detection and diagnosis of cancer and for monitoring cancer progression. ANXA2 is also required for drug-resistance. This review discusses the feasibility of ANXA2 which is active in cancer development and can be a therapeutic target in cancer management.

Original languageEnglish
Article number308976
JournalDisease Markers
Volume2014
DOIs
Publication statusPublished - 2014
Externally publishedYes

Fingerprint

Annexin A2
Annexins
Neoplasms
Post Translational Protein Processing
Drug Resistance
Peptide Hydrolases
Monitoring
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Biochemistry, medical
  • Clinical Biochemistry
  • Molecular Biology
  • Genetics
  • Medicine(all)

Cite this

Annexin A2 : Its molecular regulation and cellular expression in cancer development. / Wang, Chi Yun; Lin, Chiou Feng.

In: Disease Markers, Vol. 2014, 308976, 2014.

Research output: Contribution to journalArticle

@article{41cc5ec22f114345ad92104f846da3bf,
title = "Annexin A2: Its molecular regulation and cellular expression in cancer development",
abstract = "Annexin A2 (ANXA2) orchestrates multiple biologic processes and clinical associations, especially in cancer progression. The structure of ANXA2 affects its cellular localization and function. However, posttranslational modification and protease-mediated N-terminal cleavage also play critical roles in regulating ANXA2. ANXA2 expression levels vary among different types of cancers. With some cancers, ANXA2 can be used for the detection and diagnosis of cancer and for monitoring cancer progression. ANXA2 is also required for drug-resistance. This review discusses the feasibility of ANXA2 which is active in cancer development and can be a therapeutic target in cancer management.",
author = "Wang, {Chi Yun} and Lin, {Chiou Feng}",
year = "2014",
doi = "10.1155/2014/308976",
language = "English",
volume = "2014",
journal = "Disease Markers",
issn = "0278-0240",
publisher = "IOS Press",

}

TY - JOUR

T1 - Annexin A2

T2 - Its molecular regulation and cellular expression in cancer development

AU - Wang, Chi Yun

AU - Lin, Chiou Feng

PY - 2014

Y1 - 2014

N2 - Annexin A2 (ANXA2) orchestrates multiple biologic processes and clinical associations, especially in cancer progression. The structure of ANXA2 affects its cellular localization and function. However, posttranslational modification and protease-mediated N-terminal cleavage also play critical roles in regulating ANXA2. ANXA2 expression levels vary among different types of cancers. With some cancers, ANXA2 can be used for the detection and diagnosis of cancer and for monitoring cancer progression. ANXA2 is also required for drug-resistance. This review discusses the feasibility of ANXA2 which is active in cancer development and can be a therapeutic target in cancer management.

AB - Annexin A2 (ANXA2) orchestrates multiple biologic processes and clinical associations, especially in cancer progression. The structure of ANXA2 affects its cellular localization and function. However, posttranslational modification and protease-mediated N-terminal cleavage also play critical roles in regulating ANXA2. ANXA2 expression levels vary among different types of cancers. With some cancers, ANXA2 can be used for the detection and diagnosis of cancer and for monitoring cancer progression. ANXA2 is also required for drug-resistance. This review discusses the feasibility of ANXA2 which is active in cancer development and can be a therapeutic target in cancer management.

UR - http://www.scopus.com/inward/record.url?scp=84893796568&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893796568&partnerID=8YFLogxK

U2 - 10.1155/2014/308976

DO - 10.1155/2014/308976

M3 - Article

VL - 2014

JO - Disease Markers

JF - Disease Markers

SN - 0278-0240

M1 - 308976

ER -